Scarica l'app Stockscreener
14.64
0.54%
-0.08
Dopo l'orario di chiusura:
14.64
Precedente Chiudi:
$14.72
Aprire:
$14.66
Volume 24 ore:
1.85M
Relative Volume:
0.32
Capitalizzazione di mercato:
$7.10B
Reddito:
$4.45B
Utile/perdita netta:
$205.00M
Rapporto P/E:
36.60
EPS:
0.4
Flusso di cassa netto:
$372.00M
1 W Prestazione:
+2.38%
1M Prestazione:
+8.77%
6M Prestazione:
+22.20%
1 anno Prestazione:
+3.61%
Intervallo 1D:
$14.57
$14.81
Intervallo di 1 settimana:
$14.01
$14.81
Portata 52W:
$8.02
$15.78
Elanco Animal Health Inc Stock (ELAN) Company Profile
Nome
Elanco Animal Health Inc
Settore
Telefono
877-352-6261
Indirizzo
2500 INNOVATION WAY, GREENFIELD
Confronta ELAN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
14.64 | 7.10B | 4.45B | 205.00M | 372.00M | 0.40 |
|
RGC
Regencell Bioscience Holdings Ltd
|
22.99 | 303.95B | 0 | -5.87M | -767.30K | -0.45 |
|
ZTS
Zoetis Inc
|
159.18 | 74.39B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.16 | 48.97B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.34 | 47.39B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.08 | 20.17B | 16.54B | -1.64B | 749.00M | -1.45 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-09 | Iniziato | UBS | Buy |
| 2024-12-02 | Iniziato | Leerink Partners | Market Perform |
| 2024-09-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | Aggiornamento | Stifel | Hold → Buy |
| 2023-12-19 | Iniziato | Jefferies | Buy |
| 2023-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | Iniziato | Exane BNP Paribas | Outperform |
| 2023-04-20 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2022-08-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-07-21 | Downgrade | Goldman | Buy → Sell |
| 2022-07-12 | Iniziato | Piper Sandler | Neutral |
| 2021-11-18 | Iniziato | Morgan Stanley | Overweight |
| 2021-10-28 | Downgrade | Stifel | Buy → Hold |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-06-15 | Aggiornamento | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2021-05-11 | Aggiornamento | Gabelli & Co | Hold → Buy |
| 2021-04-15 | Iniziato | Stifel | Buy |
| 2021-03-22 | Downgrade | Gabelli & Co | Buy → Hold |
| 2021-02-26 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | Downgrade | Argus | Buy → Hold |
| 2020-11-09 | Downgrade | Barclays | Overweight → Underweight |
| 2020-08-20 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | Ripresa | Credit Suisse | Neutral |
| 2020-08-04 | Ripresa | Goldman | Buy |
| 2020-07-27 | Downgrade | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | Iniziato | Raymond James | Mkt Perform |
| 2019-12-19 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | Iniziato | Barclays | Overweight |
| 2019-08-26 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | Aggiornamento | UBS | Sell → Neutral |
| 2019-05-23 | Iniziato | Guggenheim | Neutral |
| 2019-03-18 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | Ripresa | Morgan Stanley | Equal-Weight |
| 2019-02-12 | Iniziato | William Blair | Mkt Perform |
| 2019-01-23 | Iniziato | UBS | Sell |
| 2019-01-15 | Iniziato | Argus | Buy |
| 2018-10-15 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Elanco Animal Health Inc Borsa (ELAN) Ultime notizie
Zoetis Stock Is Falling. Why the Animal-Health Company Was Downgraded. - Barron's
Elanco (ELAN) Gains Attention Amid Competitive Market Shifts | E - GuruFocus
United States Veterinary Pain Management Market Size, Share & - openPR.com
Harbor Capital Advisors Inc. Has $9.41 Million Stock Position in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from - GuruFocus
Elanco (ELAN) Awaits European Approval for Zenrelia in Dogs - GuruFocus
Elanco gains positive EMA opinion for Zenrelia for itching in dogs - Seeking Alpha
Elanco (ELAN) Awaits EU Approval for Veterinary Drug Zenrelia | ELAN Stock News - GuruFocus
Elanco’s dog allergy treatment Zenrelia gets positive EU opinion By Investing.com - Investing.com Canada
Elanco Gets 'Positive Opinion' on Canine Itch Drug From European Medicines Agency - marketscreener.com
Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from EU's Committee for Veterinary Medicinal Products (CVMP) | ELAN Stock News - GuruFocus
Elanco Receives Positive Opinion On Zenrelia From EU's Committee - MarketScreener
Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from EU's Committee for Veterinary Medicinal Products (CVMP) – Company AnnouncementFT.com - Financial Times
BiomEdit CEO: Next gen designer probiotics will disrupt the animal and human health market - AgFunderNews
Elanco Animal Health Incorporated (NYSE:ELAN) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
ELAN Q1 Earnings Call: Innovation and Product Launches Drive Outlook Amid Macro Uncertainty - Yahoo Finance
Elanco Animal Health Clears Technical Benchmark, Hitting 80-Plus RS Rating - Investor's Business Daily
Dog Owner Defends Tick Meds Suit Against Elanco, Retailers - Law360
What Makes Elanco Animal Health (ELAN) a New Buy Stock - Yahoo Finance
Is Encompass Health (EHC) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Is the Options Market Predicting a Spike in Elanco Animal Health Stock? - Yahoo Finance
Veterinary Vaccines Market Set to Surge as Global Demand - openPR.com
Elanco Animal Health Incorporated (NYSE:ELAN) Given Average Rating of “Hold” by Analysts - Defense World
Report reveals widespread impact of chronic itch in dogs - Veterinary Practice News
Elanco Releases New Report Highlighting the Significance of America's Itchy Dogs and the Need for Itch Relief - ACCESS Newswire
Elanco Animal Health Appoints Robert VanHimbergen as Chief Financial Officer - Pet Age
Elanco Releases New Report Highlighting the Significance of America's Itchy Dogs and the Need for Itch Relief | ELAN Stock News - GuruFocus
Sanders Morris Harris LLC Purchases 81,750 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Equine Healthcare Market Analysis: Trends, Key Players, - openPR.com
Animal Depression Medication Market Detailed in New Research Report | Zoetis Inc., Elanco Animal Health - openPR.com
Ameriprise Financial Inc. Has $1.18 Million Stake in Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Companion Animal Health Market -Depth Analysis, Future Trends - openPR.com
Veterinary Vaccines Market Size, Share & Forecast 2025-2033 | - openPR.com
Cetera Investment Advisers Purchases 4,553 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Elanco at Stifel Jaws & Paws: Strategic Growth and Innovation By Investing.com - Investing.com Canada
Elanco appoints Robert VanHimbergen as chief financial officer - Feed Strategy
Elanco appoints VanHimbergen as CFO - Feedstuffs
Transcript : Elanco Animal Health Incorporated Presents at Stifel Jaws & Paws Conference 2025, May-29-2025 08 - marketscreener.com
Elanco names Robert VanHimbergen as new CFO By Investing.com - Investing.com South Africa
Elanco Appoints Robert (Bob) VanHimbergen as Chief Financial Officer - citybiz
How Elanco Plans on Winning in the Pet Wellness Boom - marketscreener.com
Elanco Animal Health Incorporated Announces Change of Executive Vice President - marketscreener.com
Elanco Animal Health Incorporated Reconfirms Earnings Guidance for the Second Quarter and Full Year 2025 - marketscreener.com
Elanco Animal Health Appoints Robert VanHimbergen As CFO, Reaffirms Q2, FY25 Guidance - Nasdaq
Elanco (ELAN) Names Robert VanHimbergen as New CFO | ELAN Stock News - GuruFocus
Elanco Animal Health (ELAN) Maintains Revenue and Earnings Outlook for Q2 | ELAN Stock News - GuruFocus
Elanco Animal Health (ELAN) Reaffirms FY25 Revenue and EBITDA Ou - GuruFocus
Elanco Appoints New CFO to Drive Growth - TipRanks
Elanco names Robert VanHimbergen as new CFO - Investing.com
Elanco Appoints Robert (Bob) VanHimbergen as Chief Financial Officer | ELAN Stock News - GuruFocus
Elanco Animal Health (ELAN) Reaffirms FY25 Revenue and EBITDA Outlook | ELAN Stock News - GuruFocus
Elanco Animal Health Inc Azioni (ELAN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Elanco Animal Health Inc Azioni (ELAN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Kurzius Lawrence Erik | Director |
Mar 11 '25 |
Buy |
10.20 |
10,000 |
102,000 |
111,459 |
| HOOVER R DAVID | Director |
Mar 05 '25 |
Buy |
10.90 |
25,000 |
272,558 |
210,000 |
| Harrington Michael J | Director |
Aug 22 '24 |
Buy |
14.85 |
3,500 |
51,974 |
81,094 |
| Simmons Jeffrey N | PRESIDENT, CEO AND DIRECTOR |
Aug 12 '24 |
Buy |
13.01 |
100,000 |
1,300,610 |
145,000 |
0.21%
1.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):